Evidence map›Paper›PMID 28954635›Full record

ArticleBMC medicine2017

Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union.

Jürgen Rehm, Peter Anderson, Jose Angel Arbesu Prieto, Iain Armstrong, Henri-Jean Aubin, Michael Bachmann, Nuria Bastida Bastus, Carlos Brotons, Robyn Burton, Manuel Cardoso and 19 more

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 5 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 5 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Alcohol intake reduction for controlling hypertension.The Cochrane database of systematic reviews · 2020
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 18 institutions in 15 countries.

Jürgen RehmInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.ORCID 0000-0001-5665-0385
Peter AndersonSubstance Use, Policy and Practice, Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.
Jose Angel Arbesu PrietoPrimary Care Center La Eria, Oviedo, Spain.
Iain ArmstrongHealth and Wellbeing Directorate, Public Health England, London, UK.
Henri-Jean AubinCESP, University Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, APHP, Hôpitaux Universitaires Paris-Sud, Villejuif, France.
Michael BachmannCopentown Healthcare Consultants, Cape Town, South Africa.
Nuria Bastida BastusPrimary Health Center, Raval Nord, Barcelona, Spain.
Carlos BrotonsSardenya Primary Health Care Center, Biomedical Research Institute Sant Pau, Barcelona, Spain.
Robyn BurtonHealth and Wellbeing Directorate, Public Health England, London, UK.
Manuel CardosoGeneral Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD), Lisbon, Portugal.
Joan ColomProgram on Substance Abuse, Public Health Agency of Catalonia, Department of Health, Government of Catalonia, Barcelona, Spain.
Daniel DuprezCardiovascular Division, School of Medicine, University of Minnesota, Minneapolis, USA.
Gerrit GmelInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.
Antoni GualAddictions Unit, Psychiatry Department, Neurosciences Institute, Hospital Clinic, IDIBAPS, Barcelona, Spain.
Ludwig KrausIFT Institut für Therapieforschung, Munich, Germany.
Reinhold KreutzInstitute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Helena LiiraGeneral Practice, School of Primary, Aboriginal and Rural Health Care, University of Western Australia, Perth, Australia.
Jakob MantheyInstitute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany. jakob.manthey@tu-dresden.de.ORCID 0000-0003-1231-3760
Lars MøllerDivision of Noncommunicable Diseases through the Life Course, WHO Regional Office for Europe, Copenhagen, Denmark.
Ľubomír OkruhlicaCentrum pre Liecbu Drogovych Zavislosti, Bratislava, Slovakia.
Michael RoereckeInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.
Emanuele ScafatoNational Observatory on Alcohol, National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy.
Bernd SchulteCentre for Interdisciplinary Addiction Research, Hamburg University, Universitätsklinik Hamburg-Eppendorf, Hamburg, Germany.
Lidia Segura-GarciaProgram on Substance Abuse, Public Health Agency of Catalonia, Department of Health, Government of Catalonia, Barcelona, Spain.
Kevin David ShieldInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.
Cristina SierraHypertension and Vascular Risk Unit, Internal Medicine Department, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
Konstantin VyshinskiyResearch Institute on Addictions, Federal Medical Research Centre for Psychiatry and Narcology n.a. V. Serbsky, Moscow, Russia.
Marcin WojnarDepartment of Psychiatry, Medical University of Warsaw, Warsaw, Poland.
José ZarcoDrugs Intervention Group, semFYC, Ibiza Primary Health Care Center, Madrid, Spain.
Centre for Addiction and Mental Health · CAConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESGeneralitat de Catalunya · ESPublic Health England · GBCharité - Universitätsmedizin Berlin · DEFederal Medical Research Centre for Psychiatry and Narcology · RUInserm · FRIstituto Superiore di Sanità · ITMaastricht University · NLMedical University of Warsaw · PLSpanish Society of Family and Community Medicine · ESStockholm University · SETechnische Universität Dresden · DEUniversidad de Oviedo · ESUniversität Hamburg · DEUniversity of Helsinki · FIUniversity of Minnesota · USWorld Health Organization Regional Office for Europe · DK

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundHazardous and harmful alcohol use and high blood pressure are central risk factors related to premature non-communicable disease (NCD) mortality worldwide. A reduction in the prevalence of both risk factors has been suggested as a route to reach the global NCD targets. This study aims to highlight that screening and interventions for hypertension and hazardous and harmful alcohol use in primary healthcare can contribute substantially to achieving the NCD targets.

methodsA consensus conference based on systematic reviews, meta-analyses, clinical guidelines, experimental studies, and statistical modelling which had been presented and discussed in five preparatory meetings, was undertaken. Specifically, we modelled changes in blood pressure distributions and potential lives saved for the five largest European countries if screening and appropriate intervention rates in primary healthcare settings were increased. Recommendations to handle alcohol-induced hypertension in primary healthcare settings were derived at the conference, and their degree of evidence was graded.

resultsScreening and appropriate interventions for hazardous alcohol use and use disorders could lower blood pressure levels, but there is a lack in implementing these measures in European primary healthcare. Recommendations included (1) an increase in screening for hypertension (evidence grade: high), (2) an increase in screening and brief advice on hazardous and harmful drinking for people with newly detected hypertension by physicians, nurses, and other healthcare professionals (evidence grade: high), (3) the conduct of clinical management of less severe alcohol use disorders for incident people with hypertension in primary healthcare (evidence grade: moderate), and (4) screening for alcohol use in hypertension that is not well controlled (evidence grade: moderate). The first three measures were estimated to result in a decreased hypertension prevalence and hundreds of saved lives annually in the examined countries.

conclusionsThe implementation of the outlined recommendations could contribute to reducing the burden associated with hypertension and hazardous and harmful alcohol use and thus to achievement of the NCD targets. Implementation should be conducted in controlled settings with evaluation, including, but not limited to, economic evaluation.

Indexed as

Alcohol DrinkingBlood Pressure DeterminationEuropean UnionGuidelines as TopicHumansHypertensionRisk FactorsAlcohol useBlood pressureEuropeHypertensionManagementPrimary healthcareRecommendationsScreening

Identifiers

PMID28954635
PMCPMC5618725
OpenAlexW2756622765

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.